Association between cardiometabolic burden and secondary hypogonadism in men: a cross-sectional analysis of a US national survey and a Chinese andrology outpatient sample

Background Men with cardiometabolic abnormalities often have low total testosterone, but testosterone alone cannot show whether gonadotropins are elevated. Studies of cardiometabolic burden have rarely used luteinizing hormone (LH) to classify low testosterone, so the accompanying hypogonadism category remains unclear. Methods We analyzed total testosterone, sex hormone-binding globulin (SHBG) and the gonadotropins LH and follicle-stimulating hormone (FSH) in 2,390 men aged ≥20 years in the National Health and Nutrition Examination Survey (NHANES) August 2021–August 2023. Cardiometabolic burden was the number (0–4) of co-occurring abnormalities: adiposity, glycemic abnormality, low high-density lipoprotein cholesterol and elevated blood pressure. Men were classified by total testosterone (300 ng/dL) and LH (9.4 mIU/mL) as eugonadal or having secondary (low testosterone, non-elevated LH), primary (low testosterone, elevated LH) or compensated (normal testosterone, elevated LH) hypogonadism. Survey-weighted linear and logistic regression models were adjusted for sociodemographic, lifestyle, examination-timing and medical-history covariates. Directional consistency was assessed in 767 men from an independent Chinese andrology outpatient sample, using documented diabetes and hypertension with adjustment for age. Results Weighted proportions were 69.04% eugonadal and 19.05% secondary, 3.45% primary and 8.46% compensated hypogonadism. After adjustment, each additional abnormality was associated with 11.82% lower total testosterone (95% CI: 9.24–14.33%) and 12.71% lower SHBG (95% CI: 11.10–14.29%), whereas LH and FSH were not associated with the number of abnormalities. Relative to eugonadal men, the odds of secondary hypogonadism were higher per additional abnormality (OR = 1.96, 95% CI: 1.67–2.29), and secondary hypogonadism reached a weighted proportion of 34.25% in men with ≥3 abnormalities. In the independent clinical sample, each additional documented condition was associated with 8.04% lower total testosterone (95% CI: 3.25–12.59%) and higher odds of secondary hypogonadism (OR = 1.55, 95% CI: 1.08–2.22), but not with LH. Conclusion Greater cardiometabolic burden was associated with lower total testosterone without a corresponding rise in LH and with progressively more frequent secondary hypogonadism; a similar direction was observed in the independent clinical sample. In men with several cardiometabolic abnormalities, measuring LH alongside total testosterone may help distinguish secondary from primary hypogonadism.

Authors

Institutions

Publication Details

Journal
Frontiers in Endocrinology
Published
2026-11-20
DOI
https://doi.org/10.3389/fendo.2026.2023881
Primary Topic
Hormonal and reproductive studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Association between cardiometabolic burden and secondary hypogonadism in men: a cross-sectional analysis of a US national survey and a Chinese andrology outpatient sample

Zulong Wang, Miaomiao MA, Kaibo Su, Qi Zhang et al.
Frontiers in Endocrinology
Hormonal and reproductive studies
article

Association between cardiometabolic burden and secondary hypogonadism in men: a cross-sectional analysis of a US national survey and a Chinese andrology outpatient sample

Zulong Wang, Miaomiao MA, Kaibo Su, Qi Zhang, Hao Zhang, Shiqi Wang
article en

Abstract

Background Men with cardiometabolic abnormalities often have low total testosterone, but testosterone alone cannot show whether gonadotropins are elevated. Studies of cardiometabolic burden have rarely used luteinizing hormone (LH) to classify low testosterone, so the accompanying hypogonadism category remains unclear. Methods We analyzed total testosterone, sex hormone-binding globulin (SHBG) and the gonadotropins LH and follicle-stimulating hormone (FSH) in 2,390 men aged ≥20 years in the National Health and Nutrition Examination Survey (NHANES) August 2021–August 2023. Cardiometabolic burden was the number (0–4) of co-occurring abnormalities: adiposity, glycemic abnormality, low high-density lipoprotein cholesterol and elevated blood pressure. Men were classified by total testosterone (300 ng/dL) and LH (9.4 mIU/mL) as eugonadal or having secondary (low testosterone, non-elevated LH), primary (low testosterone, elevated LH) or compensated (normal testosterone, elevated LH) hypogonadism. Survey-weighted linear and logistic regression models were adjusted for sociodemographic, lifestyle, examination-timing and medical-history covariates. Directional consistency was assessed in 767 men from an independent Chinese andrology outpatient sample, using documented diabetes and hypertension with adjustment for age. Results Weighted proportions were 69.04% eugonadal and 19.05% secondary, 3.45% primary and 8.46% compensated hypogonadism. After adjustment, each additional abnormality was associated with 11.82% lower total testosterone (95% CI: 9.24–14.33%) and 12.71% lower SHBG (95% CI: 11.10–14.29%), whereas LH and FSH were not associated with the number of abnormalities. Relative to eugonadal men, the odds of secondary hypogonadism were higher per additional abnormality (OR = 1.96, 95% CI: 1.67–2.29), and secondary hypogonadism reached a weighted proportion of 34.25% in men with ≥3 abnormalities. In the independent clinical sample, each additional documented condition was associated with 8.04% lower total testosterone (95% CI: 3.25–12.59%) and higher odds of secondary hypogonadism (OR = 1.55, 95% CI: 1.08–2.22), but not with LH. Conclusion Greater cardiometabolic burden was associated with lower total testosterone without a corresponding rise in LH and with progressively more frequent secondary hypogonadism; a similar direction was observed in the independent clinical sample. In men with several cardiometabolic abnormalities, measuring LH alongside total testosterone may help distinguish secondary from primary hypogonadism.

Frontiers in EndocrinologyVol. 17
Henan University of Traditional Chinese Medicine (CN), Zhengzhou University (CN), Henan Cancer Hospital (CN), First Affiliated Hospital of Henan University of Traditional Chinese Medicine (CN)
National Natural Science Foundation of China, Natural Science Foundation of Henan Province
Good health and well-being
Hormonal and reproductive studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon